News

21. Oktober 2015

Noxxon: Börsengang an der Euronext geplant

20. Oktober 2015

IPO VON NOXXON PHARMA

19. Oktober 2015

Probiodrug presented data on its pGlu-3 Abeta monoclonal Antibody at Neuroscience 2015, Chicago
Presentation at the Society for Neuroscience (SfN) Annual Meeting

19. Oktober 2015

Probiodrug AG to Publish its Third Quarter 2015 Business Update on November 19, 2015

19. Oktober 2015

Probiodrug reports Third Quarter 2015 Business Update

15. Oktober 2015

Probiodrug to present at US and Japanese Conferences

12. Oktober 2015

Antibody Drug Conjugate Using CTATTM Linker Technology Shows Superior
Efficacy in Xenograft Trial. 

12. Oktober 2015

Probiodrug collaborates with the Paul-Flechsig-Institute for Brain Research, Leipzig University, Germany 

9. Oktober 2015

Vetro Solar auf dem Vormarsch - Solarglas-Unternehmen hat so viele Aufträge wie nie zuvor

7. Oktober 2015

Probiodrug signs agreement with Rentschler for manufacture of its pGlu-Abeta targeting antibody PBD-C06

Contract with German based biopharma manufacturer for clinical trials in patients with Alzheimer's disease

Seiten